Potential biomarkers: differentially expressed proteins of the extrinsic coagulation pathway in plasma samples from patients with depression

References

• Flint J, Kendler KS. The genetics of major depression. Neuron. 2014;81(5):1214.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang L, Wu Y, et al. Genome-wide study of key genes and scoring system as potential noninvasive biomarkers for detection of suicide behavior in major depression disorder. Bioengineered. 2020;11(1):1189–1196.
   PubMed Web of Science ®Google Scholar
• Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4(1):37.
   PubMedGoogle Scholar
• Pan X, Chen L, Xu W, et al. Activation of monoaminergic system contributes to the antidepressant- and anxiolytic-like effects of j147. Behav Brain Res. 2021;411(Suppl 1):113374.
   PubMedGoogle Scholar
• Zt A, Lu WA, Sl A, et al. Low bdnf levels in serum are associated with cognitive impairments in medication-nave patients with current depressive episode in bd ii and mdd. J Affect Disord. 2021;293:90–96.
   PubMed Web of Science ®Google Scholar
• Hirtz R, Libuda L, Hinney A, et al. Lack of evidence for a relationship between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axis in adolescent depression. Front Endocrinol (Lausanne). 2021;12:662243.
   PubMed Web of Science ®Google Scholar
• Lu YR, Zhang Y, Rao YB, et al. The changes in, and relationship between, plasma nitric oxide and corticotropin‐releasing hormone in patients with major depressive disorder. Clin Exp Pharmacol Physiol. 2018;45:10-15.
   Web of Science ®Google Scholar
• Milaneschi Y, Allers K, Beekman A, et al. The association between plasma tryptophan catabolites and depression: the role of symptom profiles and inflammation. Brain Behav Immun.  2021;S0889-1591(21)00271-3.
   Web of Science ®Google Scholar
• Nowacki J, Wingenfeld K, Kaczmarczyk M, et al. Cognitive and emotional empathy after stimulation of brain mineralocorticoid and nmda receptors in patients with major depression and healthy controls. Neuropsychopharmacology. 2020;45:2155–2161.
   PubMed Web of Science ®Google Scholar
• Kuhn M, Maier JG, Wolf E, et al. Indices of cortical plasticity after therapeutic sleep deprivation in patients with major depression. J Affect Disord. 2020;277:425–435.
   PubMed Web of Science ®Google Scholar
• Tuon T, Meirelles SS, Moura A, et al. Behavior and oxidative stress parameters in rats subjected to the animal’s models induced by chronic mild stress and 6-hydroxydopamine. Behav Brain Res. 2021;406:113226.
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379:1045–1055.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al. Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. J Affect Disord. 2009;119:132–141.
   PubMed Web of Science ®Google Scholar
• Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:54–63.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ishikawa M, Niitsu T, et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PloS One. 2012;7:e42676.
   PubMed Web of Science ®Google Scholar
• Kudinova AY, Gibb BE, McGeary JE, et al. Brain derived neurotrophic factor (BDNF) polymorphism moderates the interactive effect of 5-HTTLPR polymorphism and childhood abuse on diagnoses of major depression in women. Psychiatry Res. 2015;225:746–747.
   PubMed Web of Science ®Google Scholar
• Gudmand-Hoeyer J, Timmermann S, Ottesen JT. Patient-specific modeling of the neuroendocrine HPA-axis and its relation to depression: ultradian and circadian oscillations. Math Biosci. 2014;257:23–32.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31:464–468.
   PubMed Web of Science ®Google Scholar
• Van Den Eede F, Claes SJ. Mechanisms of depression: role of the HPA axis. Drug Discovery Today Dis Mech. 2004;1:413–418.
   Google Scholar
• Monk JP, Phillips G, Waite R, et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006;24:1852–1859.
   PubMed Web of Science ®Google Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31–41.
   PubMed Web of Science ®Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29–35.
   PubMed Web of Science ®Google Scholar
• Arnone D, Mumuni AN, Jauhar S, et al. Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations. Eur Neuropsychopharmacol. 2015;25:1109–1117.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Chu WJ, Whitsel RM, et al. A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder. Neuropsychobiology. 2013;67:224–229.
   PubMed Web of Science ®Google Scholar
• Xu J, Dydak U, Harezlak J, et al. Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res. 2013;213:235–241.
   PubMed Web of Science ®Google Scholar
• Schwieler L, Samuelsson M, Frye MA, et al. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J Neuroinflammation. 2016;13:51.
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Shelton RC, Kinrys G, et al. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry. 2013;18:332–339.
   PubMed Web of Science ®Google Scholar
• Wang Q, Su X, Jiang X, et al. iTRAQ technology-based identification of human peripheral serum proteins associated with depression. Neuroscience. 2016;330:291–325.
   PubMed Web of Science ®Google Scholar
• Eriksson-Berg M, Silveira A, Orth-Gomer K, et al. Coagulation factor VII in middle-aged women with and without coronary heart disease. Thromb Haemost. 2001;85:787–792.
   PubMed Web of Science ®Google Scholar
• Meyer T, Hussein S, Lange HW, et al. Transient impact of baseline depression on mortality in patients with stable coronary heart disease during long-term follow-up. Clin Res Cardiol. 2014;103:389–395.
   PubMed Web of Science ®Google Scholar
• Dhar AK, Barton DA. Depression and the Link with Cardiovascular Disease. Front Psychiatry. 2016;7:33.
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004;25:492–499.
   PubMed Web of Science ®Google Scholar
• Can MM, Guler G, Guler E, et al. Enhanced platelet reactivity in pediatric depression: an observational study. Blood Coagul Fibrin. 2015;26:731–735.
   PubMed Web of Science ®Google Scholar
• Tan YQ, Li YT, Yan TF, et al. Six immune associated genes construct prognostic model evaluate low-grade glioma. Front Immunol. 2020;11:606164.
   PubMed Web of Science ®Google Scholar
• Hidese S, Hattori K, Sasayama D, et al. Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study. Transl Psychiatry. 2020;10:161.
   PubMed Web of Science ®Google Scholar
• Saldanha NM, Suemoto CK, Rodriguez RD, et al. β-amyloid pathology is not associated with depression in a large community sample autopsy study. J Affect Disord. 2020;278:372-381.
   Web of Science ®Google Scholar
• Hu J, Wang L, Fan K, et al. The association between systemic inflammatory markers and post-stroke depression: a prospective stroke cohort. Clin Interv Aging. 2021;16:1231–1239.
   PubMed Web of Science ®Google Scholar
• Lee MY, Kim EY, Kim SH, et al. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2016;69:60–68.
   PubMed Web of Science ®Google Scholar
• Hye A, Lynham S, Thambisetty M, et al. Proteome-based plasma biomarkers for Alzheimer’s disease. Brain. 2006;129:3042–3050.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33;quiz 4–57.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Ma YJ, Zhou YJ, Wang DF, et al. Association of lipid profile and suicide attempts in a large sample of first episode drug-naive patients with major depressive disorder. Front Psychiatry. 2020;11:543632.
   PubMed Web of Science ®Google Scholar
• Leurs J, Nerme V, Sim Y, et al. Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism. J Thromb Haemost. 2010;2(3):416–423.
   Google Scholar
• Zhang G, Xu S, Yuan Z, et al. Weighted gene coexpression network analysis identifies specific modules and hub genes related to major depression. Neuropsychiatr Dis Treat. 2020;16:703–713.
   PubMed Web of Science ®Google Scholar
• Ni G, Liu G, Yu K. Identification of key genes associated with the effect of osmotic stimuli on intervertebral discs using microarray analysis. Oncol Lett. 2017;14:4249–4255.
   PubMed Web of Science ®Google Scholar
• Martins-De-Souza D, Maccarrone G, Ising M, et al. Plasma fibrinogen: now also an antidepressant response marker? Transl Psychiatry. 2014;4(1):e352.
   PubMedGoogle Scholar
• Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89:419–424.
   PubMed Web of Science ®Google Scholar
• Känel RV, Bellingrath S, Kudielka BM. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiology. 2010;46:473–480.
   Web of Science ®Google Scholar
• Wium-Andersen MK, Ørsted DD, Nordestgaard BG. Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: two large population-based studies. Psychoneuroendocrinology. 2013;38:638–647.
   PubMed Web of Science ®Google Scholar
• Donati MB, Iacoviello L. Fibrinogen and factor viic levels: independent risk factors or markers of coronary disease risk? J Thromb Haemost. 2010;5(3):458–460.
   Google Scholar
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–1980.
   PubMed Web of Science ®Google Scholar
• Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50:627–633.
   PubMed Web of Science ®Google Scholar
• Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation. 1996;94:3123–3129.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Charles E, Kass F. Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry. 1983;140:1072–1074.
   PubMed Web of Science ®Google Scholar
• Carney RM, Rich MW, Tevelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273–1275.
   PubMed Web of Science ®Google Scholar
• Sultzer DL, Levin HS, Mahler ME, et al. A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am J Psychiatry. 1993;150:1806–1812.
   PubMed Web of Science ®Google Scholar
• Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology. 1989;39:349–354.
   PubMed Web of Science ®Google Scholar
• Kuijpers PM, Hamulyak K, Strik JJ, et al. Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Res. 2002;109:207–210.
   PubMed Web of Science ®Google Scholar
• Marmur JD, Thiruvikraman SV, Fyfe BS, et al. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226–1232.
   PubMed Web of Science ®Google Scholar
• Townsend TN, Lazarchick J, Greenberg CS, et al. Factor vii deficiency in african american individuals. presentation, diagnosis and management.a single medical center experience. Blood. 2013;122(21):4779.
   Web of Science ®Google Scholar
• Doulalas AD, Rallidis LS, Gialernios T, et al. Association of depressive symptoms with coagulation factors in young healthy individuals. Atherosclerosis. 2006;186:121–125.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen J, Liu C, et al. The extrinsic coagulation pathway: a biomarker for suicidal behavior in major depressive disorder. Sci Rep. 2016;6:32882.
   PubMed Web of Science ®Google Scholar
• Sreekumar O, Nicole B, Donald B, et al. Upregulation of mirna-4776 in influenza virus infected bronchial epithelial cells is associated with downregulation of nfkbib and increased viral survival. Viruses. 2017;9(5):94.
   PubMed Web of Science ®Google Scholar
• Vito J, Palombella, Oliver J, et al. The ubiquitinproteasome pathway is required for processing the nf-κb1 precursor protein and the activation of nf-κb. Cell. 1994;78:773–785.
   PubMed Web of Science ®Google Scholar
• Kemler I, Fontana A. Role of IκBα and IκBβ in the biphasic nuclear translocation of NF‐κB in TNFα‐stimulated astrocytes and in neuroblastoma cells. Glia. 2015;26:212–220.
   Google Scholar
• Rao P, Hayden MS, Long M, et al. IκBβ acts to inhibit and activate gene expression during the inflammatory response. Nature. 2010;466:1115–1119.
   PubMed Web of Science ®Google Scholar
• Li H, Lin S, Qin T, et al. Senegenin exerts anti-depression effect in mice induced by chronic un-predictable mild stress via inhibition of NF-κB regulating NLRP3 signal pathway. Int Immunopharmacol. 2017;53:24–32.
   PubMed Web of Science ®Google Scholar
• Shao RH, Jin SY, Jun LU, et al. Effect of acupuncture intervention on expression of NF-κB signal pathway in the hippocampus of chronic stress-induced depression rats. Acupuncture Res. 2015;40:368.
   Google Scholar
• Boissière F, Hunot S, Faucheux B, et al. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer’s disease. Neuroreport. 1997;8:2849–2852.
   PubMed Web of Science ®Google Scholar
• Hunot S, Brugg B, Ricard D, et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A. 1997;94:7531–7536.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Roy A, Liu X, et al. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A. 2007;104:18754–18759.
   PubMed Web of Science ®Google Scholar
• Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21:1358–1365.
   PubMed Web of Science ®Google Scholar
• Zalli A, Jovanova O, Hoogendijk WJ, et al. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berl). 2016;233:1669–1678.
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Nierenberg AA, Schettler PJ, et al. Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry. 2016;21:71–79.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Granger DN. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis. 2009;15:1245–1255.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
   PubMed Web of Science ®Google Scholar
• Arrigo AP, Gibert B. Protein interactomes of three stress inducible small heat shock proteins: hspB1, HspB5 and HspB8. Int J Hyperthermia. 2013;29(5):409–422.
   PubMed Web of Science ®Google Scholar
• Brunet M, Didelot C, Subramaniam S, et al. Hsp70 and Hsp27 as pharmacological targets in apoptosis modulation for cancer therapy. Heat Shock Proteins Cancer. 2007;2:209–229.
   Google Scholar
• Kim J, Lim H, Kim S, et al. Effects of HSP27 downregulation on PDT resistance through PDT-induced autophagy in head and neck cancer cells. Oncol Rep. 2016;35:2237.
   PubMed Web of Science ®Google Scholar
• Lu KT, Wang BY, Chi WY, et al. Ovatodiolide inhibits breast cancer stem/progenitor cells through SMURF2-mediated downregulation of Hsp27. Toxins (Basel). 2016;8:127.
   PubMed Web of Science ®Google Scholar
• Renkawek K, Bosman GJ, de Jong WW. Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol. 1994;87:511.
   PubMed Web of Science ®Google Scholar
• Renkawek K, Bosman GJ, Gaestel M. Increased expression of heat-shock protein 27 kDa in Alzheimer disease: a preliminary study. Neuroreport. 1993;5:14–16.
   PubMed Web of Science ®Google Scholar
• Renkawek K, Stege GJ, Bosman GJ. Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson’s disease. Neuroreport. 1999;10:2273–2276.
   PubMed Web of Science ®Google Scholar
• Kirschstein T, Mikkat S, Mikkat U, et al. The 27-kDa heat shock protein (HSP27) is a reliable hippocampal marker of full development of pilocarpine-induced status epilepticus. Epilepsy Res. 2012;98:35–43.
   PubMed Web of Science ®Google Scholar
• Trystuła M, Wilkfrańczuk MŻ, Kropotov JD, et al. CASE-REPORT Dysregulation of gene expression in a patient with depressive disorder after transient ischemic attack confirmed by a neurophysiological neuromarker. Genet Mol Res. 2017;16:1-11.
   Google Scholar
• Hjemdahl P, Känel R. Haemostatic effects of stress. Springer, London. 2012.
   Google Scholar
• Von KR, Mills PJ, Fainman C, et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63:531.
   PubMed Web of Science ®Google Scholar
• Pae CU, Mandelli L, Serretti A, et al. Heat-shock protein-70 genes and response to antidepressants in major depression. Prog Neuro Psychopharmacol Biol Psychiatry. 2007;31:1006–1011.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Nomura K, Ujihara M, et al. An allel-specific abnormal transcript of the heat shock protein 70 gene in patients with major depression. Biochem Biophys Res Commun. 1996;219:745–752.
   PubMed Web of Science ®Google Scholar
• Todtenkopf MS, Marcus JF, Portoghese PS, et al. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl). 2004;172:463–470.
   PubMed Web of Science ®Google Scholar
• Carr GV, Bangasser DA, Bethea T, et al. Antidepressant-like effects of |[kappa]|-opioid receptor antagonists in wistar kyoto rats. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2010;35:752.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun H, Chen H, et al. Major depressive disorder and kappa opioid receptor antagonists. Transl Perioperative Pain Med. 2016;1(2):4–16.
   PubMedGoogle Scholar